RETROVIRAL THERAPEUTICS Trademark

Trademark Overview

On Friday, April 7, 2023, a trademark application was filed for RETROVIRAL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the RETROVIRAL THERAPEUTICS trademark a serial number of 97877961. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, September 3, 2024. This trademark is owned by Retroviral Therapeutics LLC. The RETROVIRAL THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Vaccines; Biological preparations for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Medical preparations for the treatment of diseases, disorders and illnesses, namely, infectious diseases, cancer, osteporosis, kidney diseases, liver diseases, viral infections, and for use in oncology and retroviruses; Pharmaceutical preparations for the treatment and prevention of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Therapeutic pharmaceutical for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Therapeutic vaccines

Bacteriological research and analysis; Bacteriological research and testing; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials involving viruses used for clinical and treatment purposes; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific and technological services, namely, design, engineering, research, development and testing in the field of immunopharmaceuticals and vaccines involving viruses used for clinical and treatment purposes
retroviral therapeutics

General Information

Serial Number97877961
Word MarkRETROVIRAL THERAPEUTICS
Filing DateFriday, April 7, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesVaccines; Biological preparations for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Medical preparations for the treatment of diseases, disorders and illnesses, namely, infectious diseases, cancer, osteporosis, kidney diseases, liver diseases, viral infections, and for use in oncology and retroviruses; Pharmaceutical preparations for the treatment and prevention of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Therapeutic pharmaceutical for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Therapeutic vaccines
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesBacteriological research and analysis; Bacteriological research and testing; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials involving viruses used for clinical and treatment purposes; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific and technological services, namely, design, engineering, research, development and testing in the field of immunopharmaceuticals and vaccines involving viruses used for clinical and treatment purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 2, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 2, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRetroviral Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLincoln, MA 01773

Trademark Events

Event DateEvent Description
Tuesday, April 11, 2023NEW APPLICATION ENTERED
Friday, December 29, 2023ASSIGNED TO EXAMINER
Wednesday, January 10, 2024NON-FINAL ACTION WRITTEN
Wednesday, January 10, 2024NON-FINAL ACTION E-MAILED
Wednesday, January 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 10, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 10, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 16, 2024FINAL REFUSAL WRITTEN
Thursday, May 16, 2024FINAL REFUSAL E-MAILED
Thursday, May 16, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, September 3, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, September 3, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords

therapeutics retroviral diseases treatment namely research viral liver infections infectious retroviruses vaccines